These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9342076)

  • 1. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
    Galgani S; Balestra P; Narciso P; Tozzi V; Sette P; Pau F; Visco G
    AIDS; 1997 Oct; 11(12):1520-1. PubMed ID: 9342076
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful zidovudine (AZT) treatment in a case of human immunodeficiency virus (HIV)-1-associated dementia complex.
    Sobanski T; Assion HJ; Scholl HP; Höflich G; Laux G
    Biol Psychiatry; 1996 Jun; 39(12):1065-6. PubMed ID: 8780847
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I/II trial of nimodipine for HIV-related neurologic complications.
    Navia BA; Dafni U; Simpson D; Tucker T; Singer E; McArthur JC; Yiannoutsos C; Zaborski L; Lipton SA
    Neurology; 1998 Jul; 51(1):221-8. PubMed ID: 9674806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of HIV encephalopathy with dementia which showed significant improvement after the combination antiretroviral therapy].
    Mizoi Y; Takagi M; Hoshino H; Matsuoka S; Adachi T
    Rinsho Shinkeigaku; 2000 Feb; 40(2):178-80. PubMed ID: 10835942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
    Simpson DM
    Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
    Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC
    J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of the development of dementia after interruption of zidovudine treatment].
    Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
    Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information processing and antiretroviral therapy in HIV-1 infection.
    Martin EM; Pitrak DL; Pursell KJ; Andersen BR; Mullane KM; Novak RM
    J Int Neuropsychol Soc; 1998 Jul; 4(4):329-35. PubMed ID: 9656606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism with HIV infection.
    Mirsattari SM; Power C; Nath A
    Mov Disord; 1998 Jul; 13(4):684-9. PubMed ID: 9686775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.
    Goodgame JC; Pottage JC; Jablonowski H; Hardy WD; Stein A; Fischl M; Morrow P; Feinberg J; Brothers CH; Vafidis I; Nacci P; Yeo J; Pedneault L
    Antivir Ther; 2000 Sep; 5(3):215-25. PubMed ID: 11075942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
    Bocket L; Yazdanpanah Y; Ajana F; Gerard Y; Viget N; Goffard A; Alcaraz I; Wattré P; Mouton Y
    J Antimicrob Chemother; 2004 Jan; 53(1):89-94. PubMed ID: 14645320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biologic features of the AIDS dementia complex.
    Navia BA
    Neuroimaging Clin N Am; 1997 Aug; 7(3):581-92. PubMed ID: 9376969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Past, present and future of zidovudine, the first antiretroviral drug].
    Martín Fernández J; Rubio García R; Pulido Ortega F
    An Med Interna; 1998 Mar; 15(3):163-70. PubMed ID: 9567426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.